Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1)

Arthritis Research and Therapy

Volumn 8, Issue 1, 2005, Pages

  Hückel, Marion ^a   Schurigt, Uta ^a   Wagner, Andreas H ^b   Stöckigt, Renate ^a   Petrow, Peter K ^a   Thoss, Klaus ^a   Gajda, Mieczyslaw ^a   Henzgen, Steffen ^c   Hecker, Markus ^b   Bräuer, Rolf ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Dietrich Bonhoeffer Clinical Centre   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70350503333     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1869     Document Type: Article

References (56)

1. Cush JJ, Lipsky PE: Cellular basis for rheumatoid inflammation. Clin Orthop 1991, 265:9-22.
2. Gay S, Gay RE, Koopman WJ: Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: Two cellular mechanisms explain joint destruction? Ann Rheum Dis 1993, 52(Suppl 1): S39-47.
3. Miltenburg AM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC: T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol 1992, 35 603-610.
4. Adorini L, Guery JC, Trembleau S: Manipulation of the Th1/Th2 cell balance: An approach to treat human autoimmune diseases? Autoimmunity 1996, 23:53-68.
5. Leonard WJ: Role of Jak kinases and STATs in cytokine signal transduction. Int J Hematol 2001, 73:271-277.
6. Schindler CW: Series introduction. JAK-STAT signaling in human disease. J Clin Invest 2002, 109:1133-1137.
7. Ivashkiv LB, Hu X: The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective? Arthritis Rheum 2003, 48 2092-2096.
8. van der Pouw Kraan TC, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets TJ, Kraan MC, Fero M, Tak PP, Huizinga TW, Pieterman E, et al. Rheumatoid arthritis is a heterogeneous disease: Evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 2003, 48:2132-2145.
9. Yokota A, Narazaki M, Shima Y, Murata N, Tanaka T, Suemura M, Yoshizaki K, Fujiwara H, Tsuyuguchi I, Kishimoto T: Preferential and persistent activation of the STAT1 pathway in rheumatoid synovial fluid cells. J Rheumatol 2001, 28:1952-1959.
10. Kasperkovitz PV, Verbeet NL, Smeets TJ, van Rietschoten JG, Kraan MC, van der Pouw Kraan TC, Tak PP, Verweij CL: Activation of the STAT1 pathway in rheumatoid arthritis. Ann Rheum Dis 2004, 63 233-239.
11. Nguyen VT, Benveniste EN: Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/ macrophages. J Biol Chem 2000, 275:23674-23684.
12. Wagner AH, Gebauer M, Pollok-Kopp B, Hecker M: Cytokineinducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1. Blood 2002, 99:520-525.
13. Frucht DM, Aringer M, Galon J, Danning C, Brown M, Fan S, Centola M, Wu CY, Yamada N, El Gabalawy H, O' Shea JJ: Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J Immunol 2000, 164 4659-4664.
14. Muller-Ladner U, Judex M, Ballhorn W, Kullmann F, Distler O, Schlottmann K, Gay RE, Scholmerich J, Gay S: Activation of the IL-4 STAT pathway in rheumatoid synovium. J Immunol 2000, 164:3894-3901.
15. Hu X, Herrero C, Li WP, Antoniv TT, Falck-Pedersen E, Koch AE, Woods JM, Haines GK, Ivashkiv LB: Sensitization of IFN-gamma Jak-STAT signaling during macrophage activation. Nat Immunol 2002, 3:859-866.
16. Ortmann RA, Cheng T, Visconti R, Frucht DM, O'Shea JJ: Janus kinases and signal transducers and activators of transcription: Their roles in cytokine signaling, development and immunoregulation. Arthritis Res 2000, 2:16-32.
17. Quandt K, Frech K, Karas H, Wingender E, Werner T: MatInd and MatInspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995, 23:4878-4884.
18. Ehret GB, Reichenbach P, Schindler U, Horvath CM, Fritz S, Nabholz M, Bucher P: DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J Biol Chem 2001, 276:6675-6688.
19. Austrup F, Vestweber D, Borges E, Löhning M, Bräuer R, Herz U, Renz H, Hallmann R, Scheffold A, Radbruch A, Hamann A: P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 1997, 385:81-83.
20. Simon J, Surber R, Kleinstäuber G, Petrow PK, Henzgen S, Kinne RW, Bräuer R: Systemic macrophage activation in locally induced experimental arthritis. J Autoimmun 2001, 17:127-136.
21. Mentzel K, Bräuer R: Matrix metalloproteinases, IL-6, and nitric oxide in rat antigen-induced arthritis. Clin Exp Rheumatol 1998, 16:269-276.
22. Wagner AH, Krzesz R, Gao D, Schroeder C, Cattaruzza M, Hecker M: Decoy oligodeoxynucleotide characterization of transcription factors controlling endothelin-B receptor expression in vascular smooth muscle cells. Mol Pharmacol 2000, 58:1333-1340.
23. Mann MJ, Conte MS: Transcription factor decoys for the prevention of vein bypass graft failure. Am J Cardiovasc Drugs 2003, 3 79-85.
24. Buchwald AB, Wagner AH, Webel C, Hecker M: Decoy oligodeoxynucleotide against activator protein-1 reduces neointimal proliferation after coronary angioplasty in hypercholesterolemic minipigs. J Am Coll Cardiol 2002, 39:732-738.
25. Kelkenberg U, Wagner AH, Sarhaddar J, Hecker M, von der Leyen HE: CCAAT/enhancer-binding protein decoy oligodeoxynucleotide inhibition of macrophage-rich vascular lesion formation in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol 2002, 22:949-954.
26. Pohlers D, Nissler K, Frey O, Simon J, Petrow PK, Kinne RW, Bräuer R: Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: Influence on T helper cell activation. Clin Exp Immunol 2004, 135:409-415.
27. Krzesz R, Wagner AH, Cattaruzza M, Hecker M: Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor kappaB and signal transducer and activation of transcription-1 FEBS Lett 1999, 453:191-196.
28. Horvath CM, Wen Z, Darnell JE Jr: A STAT protein domain that determines DNA sequence recognition suggests a novel DNAbinding domain Genes Dev 1995, 9:984-994.
29. Mynard V, Guignat L, Devin-Leclerc J, Bertagna X, Catelli MG: Different mechanisms for leukemia inhibitory factor-dependent activation of two proopiomelanocortin promoter regions. Endocrinology 2002, 143:3916-3924.
30. Korzus E, Nagase H, Rydell R, Travis J: The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J Biol Chem 1997, 272:1188-1196.
31. Quarcoo D, Weixler S, Groneberg D, Joachim R, Ahrens B, Wagner AH, Hecker M, Hamelmann E: Inhibition of signal transducer and activator of transcription 1 attenuates allergen-induced airway inflammation and hyperreactivity. J Allergy Clin Immunol 2004, 114:288-295.
32. Durbin JE, Hackenmiller R, Simon MC, Levy DE: Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 1996, 84:443-450.
33. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, Kaplan DH, Riley JK, Greenlund AC, Campbell D, et al.: Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996, 84:431-442.
34. Gil MP, Bohn E, O'Guin AK, Ramana CV, Levine B, Stark GR, Virgin HW, Schreiber RD: Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci USA 2001, 98:6680-6685.
35. Ramana CV, Gil MP, Han Y, Ransohoff RM, Schreiber RD, Stark GR: Stat1-independent regulation of gene expression in response to IFN-gamma Proc Natl Acad Sci USA 2001, 98:6674-6679.
36. Chin YE, Kitagawa M, Kuida K, Flavell RA, Fu XY: Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis Mol Cell Biol 1997, 17:5328-5337.
37. Lee CK, Smith E, Gimeno R, Gertner R, Levy DE: STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-gamma. J Immunol 2000, 164:1286-1292.
38. Bromberg J, Darnell JE Jr: The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000, 19:2468-2473.
39. Krause A, Scaletta N, Ji JD, Ivashkiv LB: Rheumatoid arthritis synoviocyte survival is dependent on Stat3. J Immunol 2002, 169:6610-6616.
40. de Hooge AS, van de Loo FA, Koenders MI, Bennink MB, Arntz OJ, Kolbe T, van den Berg WB: Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: Exacerbation of joint inflammation in STAT-1 geneknockout mice. Arthritis Rheum 2004, 50:2014-2023.
41. Nishibori T, Tanabe Y, Su L, David M: Impaired development of CD4+ CD25+ regulatory T cells in the absence of STAT1: Increased susceptibility to autoimmune disease. J Exp Med 2004, 199 25-34.
42. Lucas DM, Lokuta MA, McDowell MA, Doan JE, Paulnock DM: Analysis of the IFN-gamma-signaling pathway in macrophages at different stages of maturation. J Immunol 1998, 160:4337-4342.
43. Schurigt U, Stopfel N, Hückel M, Pfirschke C, Wiederanders B, Bräuer R: Local expression of matrix metalloproteinases, cathepsins, and their inhibitors during the development of murine antigen-induced arthritis. Arthritis Res Ther 2005, 7 R174-188.
44. Delgado M, Ganea D: Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. J Immunol 2000, 165:3051-3057.
45. Seidel HM, Milocco LH, Lamb P, Darnell JE Jr, Stein RB, Rosen J: Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci USA 1995, 92 3041-3045.
46. Nissler K, Pohlers D, Hückel M, Simon J, Bräuer R, Kinne RW: Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: Influence on macrophage activation. Ann Rheum Dis 2004, 63:1470-1477.
47. Wesemann DR, Dong Y, O'Keefe GM, Nguyen VT, Benveniste EN: Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages. J Immunol 2002, 169:2354-2360.
48. Nguyen VT, Benveniste EN: Critical role of tumor necrosis factor-alpha and NF-kappa B in interferon-gamma-induced CD40 expression in microglia/macrophages. J Biol Chem 2002, 277 13796-13803.
49. Ruth AJ, Kitching AR, Li M, Semple TJ, Timoshanko JR, Tipping PG, Holdsworth SR: An IL-12-independent role for CD40-CD154 in mediating effector responses: Studies in cell-mediated glomerulonephritis and dermal delayed-type hypersensitivity. J Immunol 2004, 173 136-144.
50. Harigai M, Hara M, Nakazawa S, Fukasawa C, Ohta S, Sugiura T, Inoue K, Kashiwazaki S: Ligation of CD40 induced tumor necrosis factor-alpha in rheumatoid arthritis: A novel mechanism of activation of synoviocytes J Rheumatol 1999, 26:1035-1043.
51. Rissoan MC, Van Kooten C, Chomarat P, Galibert L, Durand I, Thivolet Bejui F, Miossec P, Banchereau J: The functional CD40 antigen of fibroblasts may contribute to the proliferation of rheumatoid synovium Clin Exp Immunol 1996, 106:481-490.
52. Kitagawa M, Suzuki H, Adachi Y, Nakamura H, Yoshino S, Sumida T: Interferon-gamma enhances interleukin 12 production in rheumatoid synovial cells via CD40-CD154 dependent and independent pathways. J Rheumatol 2001, 28:1764-1771.
53. Mottonen M, Isomaki P, Luukkainen R, Lassila O: Regulation of CD154-induced interleukin-12 production in synovial fluid macrophages Arthritis Res 2002, 4:R9.
54. Harigai M, Hara M, Kawamoto M, Kawaguchi Y, Sugiura T, Tanaka M, Nakagawa M, Ichida H, Takagi K, Higami-Ohsako S, et al.: Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis. Arthritis Rheum 2004, 50:2167-2177.
55. Rissoan MC, Van Kooten C, Chomarat P, Galibert L, Durand I, Thivolet-Bejui F, Miossec P, Banchereau J: The functional CD40 antigen of fibroblasts may contribute to the proliferation of rheumatoid synovium. Clin Exp Immunol 1996, 106:481-490.
56. Yellin MJ, Winikoff S, Fortune SM, Baum D, Crow MK, Lederman S, Chess L: Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J Leukoc Biol 1995, 58:209-216.